13 Einträge gefunden

1. CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy

   1. Pape, Luca Julius
   2. Hambach, Julia
   3. Gebhardt, Anna Josephine
   4. Rissiek, Björn
   5. Stähler, Tobias
   6. Tode, Natalie
   7. Khan, Cerusch

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells

   1. Hambach, Julia
   2. Fumey, William
   3. Stähler, Tobias
   4. Gebhardt, Anna Josephine
   5. Adam, Gerhard
   6. Weisel, Katja
   7. Koch-Nolte, Friedrich

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors

   1. Hambach, Julia
   2. Mann, Anna Marei
   3. Bannas, Peter
   4. Koch-Nolte, Friedrich

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells

   1. Baum, Natalie
   2. Fliegert, Ralf
   3. Bauche, Andreas
   4. Hambach, Julia
   5. Menzel, Stephan
   6. Haag, Friedrich
   7. Bannas, Peter

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Monitoring Expression and Enzyme Activity of Ecto-ARTCs

   1. Menzel, Stephan
   2. Adriouch, Sahil
   3. Bannas, Peter
   4. Haag, Friedrich
   5. Koch-Nolte, Friedrich

   2018 - Forschungsinformationssystem des UKE
6. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma

   1. Bannas, Peter
   2. Koch-Nolte, Friedrich

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
7. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics

   1. Bannas, Peter
   2. Hambach, Julia
   3. Koch-Nolte, Friedrich

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
8. Long-term CD38 saturation by daratumumab interferes with diagnostic myeloma cell detection

   1. Oberle, Anna
   2. Brandt, Anna
   3. Alawi, Malik
   4. Langebrake, Claudia
   5. Janjetovic, Snjezana
   6. Wolschke, Christine
   7. Schütze, Kerstin

   2017 - Forschungsinformationssystem des UKE
9. Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

   1. Bannas, Peter
   2. Lenz, Alexander
   3. Kunick, Valentin
   4. Fumey, William
   5. Rissiek, Björn
   6. Schmid, Joanna
   7. Haag, Friedrich

   2015 - Forschungsinformationssystem des UKE
10. Extracellular NAD and ATP: Partners in immune cell modulation.

    1. Haag, Friedrich
    2. Adriouch, Sahil
    3. Brass, Anette
    4. Jung, Caroline
    5. Hübener, Sina
    6. Scheuplein, Felix
    7. Bannas, Peter

    2007 - Forschungsinformationssystem des UKE
11. ADP-ribosylation of membrane proteins: unveiling the secrets of a crucial regulatory mechanism in mammalian cells.

    1. Koch-Nolte, Friedrich
    2. Adriouch, Sahil
    3. Bannas, Peter
    4. Krebs, Christian
    5. Scheuplein, Felix
    6. Seman, Michel
    7. Haag, Friedrich

    2006 - Forschungsinformationssystem des UKE
12. Use of genetic immunization to raise antibodies recognizing toxin-related cell surface ADP-ribosyltransferases in native conformation.

    1. Koch-Nolte, Friedrich
    2. Glowacki, Gustavo
    3. Bannas, Peter
    4. Braasch, Fenja
    5. Dubberke, Gudrun
    6. Ortolan, Erika
    7. Funaro, Ada

    2005 - Forschungsinformationssystem des UKE
13. Activity and specificity of toxin-related mouse T cell ecto-ADP-ribosyltransferase ART2.2 depends on its association with lipid rafts.

    1. Bannas, Peter
    2. Adriouch, Sahil
    3. Kahl, Sarah
    4. Braasch, Fenja
    5. Haag, Friedrich
    6. Koch-Nolte, Friedrich

    2005 - Forschungsinformationssystem des UKE